Advanced search
Companies (2)
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
Capitalization | 10 M USD |
---|---|
Change | +5.63% |
1-year price change | +22.69% |
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
Capitalization | 10 M USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
- Stock Market
- Advanced search
- Mikael Dolsten
- Company Profiles